Objective To evaluate the reproducibility of blood pressure measured at home (HBP) in comparison with ambulatory (ABP) and clinic blood pressure (CBP) in children and adolescents.
Introduction
Clinic blood pressure (CBP) is still regarded as the cornerstone of hypertension diagnosis and treatment in both adults [1, 2] and children [3] . However, CBP is poorly reproducible, is subject to the white-coat effect and the placebo effect [4] and in the individual is a poor predictor of cardiovascular risk [5] .
Out-of-clinic BP measurements using ambulatory (ABP) or home blood pressure monitoring (HBP) have been shown to provide more reproducible BP values [4, 6] , which are free from the white-coat effect [4, 7] and more predictive of future cardiovascular events [5] . In recent years, several official bodies recommend the use of ABP and HBP as supplementary sources of information to the practicing physician [1, 2, 4] .
Several studies have been reported using ambulatory BP monitoring in children [8] [9] [10] [11] [12] [13] and the normal range for such measurements has been proposed using percentiles from a cross-sectional study [8] . On the other hand, there is little evidence about HBP in children and adolescents. Despite the lack of data, HBP measurements are being used in clinical practice for the evaluation of out-of-office BP in children [14] .
Reproducibility is an important feature of the reliability of a BP measurement method and has important implications for both clinical practice and research [15] . Studies in adults have consistently shown ABP measurements to be more reproducible than CBPs [6, [16] [17] [18] [19] and some evidence suggests that this is also the case in children [12, 13] . In regard to HBP, studies in adults again showed superior reproducibility compared to CBPs [6, [18] [19] [20] , whereas in children such information is lacking. This study was designed to evaluate the reproducibility of HBP in comparison to ABP and CBP in children and adolescents and to assess its implications on the accuracy of clinical trials of antihypertensive drug efficacy.
Patients and methods

Study participants
Children and adolescents aged 8-17 years referred for elevated BP (measured on at least two occasions) were recruited. Exclusion criteria were history of hypertension, CBP > 160/110 mmHg on the first two clinic visits, systemic or renal disease and treatment with antihypertensive or other medication that might influence BP.
Blood pressure measurements
Participants were asked to measure HBP for 2 weeks or ABP for 24 h. The alternative measurement was then performed. CBP was measured in three visits within 3 weeks. A second session including all the above CBP, HBP and ABP measurements was performed after at least 4 weeks. No subject received antihypertensive treatment throughout the study. Participants' parents gave informed consent for study participation. CBP measurements were taken by three physicians who fulfilled the British Hypertension Society Protocol criteria for observer agreement in BP measurement [21] . Triplicate BP measurements were taken at each clinic visit after 5 min sitting rest and with at least 1 min between recordings by using a standard mercury sphygmomanometer (cuff with bladder size 9 cmÂ 18 cm, 12 cmÂ 23 cm or 15 cmÂ 35 cm according to arm circumference, Korotkoff phase V for diastolic BP or IV when sounds could be heard to 0 mmHg). HBP was measured on three routine school days per week for 2 weeks using validated fully automated electronic devices Omron HEM-705CP or Omron IC [22, 23] (Omron Healthcare GmbH, Hamburg, Germany; bladder size 12 cm Â 23 cm or 14 cm Â 28 cm where appropriate), apart from children with arm circumference < 20 cm in whom Omron 711 IS was used (bladder size 9 cm Â 16 cm) [24] . Participants were trained in the conditions of HBP measurement and the use of the electronic devices and were instructed to make duplicate morning (0600-1000 h) and evening (1800-2200 h) self-measurements after 5 min sitting rest and with 1 min between measurements. In the younger children HBP measurements were taken by their parents. Further to the device memory storage and printout, a form was supplied to the participants to report all HBP values.
ABP was monitored either before or after HBP monitoring using validated non-invasive portable oscillometric devices SpaceLabs 90207 or 90217 (SpaceLabs Inc, Redmond, Washington, USA, bladder size 9 cm Â 16 cm or 12 cm Â 23 cm where appropriate) [23] . The recorders were programmed to measure BP at 20-min intervals for 24 h and were applied on a routine school day. Subjects were instructed to follow their usual daily activities but to remain still with the forearm extended during each BP reading. A brief diary specifying the time when they went to bed and arose was kept by the children or their parents. Before each HBP or ABP monitoring session, the accuracy of the devices was tested against a standard mercury sphygmomanometer by manual activation (three succeeding readings; Y connector).
Analysis
Subjects who provided less than 12 valid HBP readings or readings taken on less than 4 days either in the initial or the second session were excluded from the analysis as were subjects with fewer than two clinic visits for each session. ABP recordings with less than 30 successful awake measurements and/or less than 12 measurements while asleep were excluded from the analysis. BP measurements flagged by the software of the monitors as technically erroneous were excluded. Early readings taken less than 20 min after the monitor was attached to patient were also excluded as these were taken in the clinic environment. Average daytime, night-time and 24-h ABP were calculated according to individual subjects' sleeping hours (awake and asleep periods). The criteria of 1996 Updated Task Force Report on high blood pressure in children and adolescents [3] were used for the classification of hypertension (mean CBP Z 95th percentile for sex, age and height), highnormal blood pressure (90-95th percentile) and normotension ( < 90th percentile).
The reproducibility of the average (a) CBP of one visit (second visit of each session), (b) HBP of 4 days (days 2-5 of each session) and (c) 24-h, awake and asleep ABP was quantified using test-retest correlations coefficients (r) and the standard deviation (SD) of differences between repeated measurements [15] . For each BP measurement method, the number of subjects required for a trial comparing the antihypertensive efficacy of two drugs with power 0.90 and two-sided significance level 0.05, was calculated using the formulas [15] [4(z a + z b ) 2 s 2 ]/d 2 = number of subjects required in a parallel trial and [(z a + z b ) 2 s 2 ]/d 2 in a crossover trial (z a , z b , ordinates for the normal distribution; s, estimated SD of differences between BP measurements; d, clinically important BP difference between measurements, systolic Z 10 mmHg or diastolic Z 5 mmHg).
Statistical analysis was performed using the MINITAB INC Statistical Software (release 13.31) (Stage College, Pennsylvania, USA). Student's paired t-tests were used for the comparison of CBP, HBP and ABP measurements and Pearson correlations for the evaluation of the association between repeated measurements. A probability value P < 0.05 was considered statistically significant.
Results
A total of 16 children and adolescents were recruited [mean age, 13.3 ± 2.9 (SD) years; range, 8 to 17 years, nine boys and seven girls]. No subject was lost to followup or was excluded because of inadequate BP measurements. According to US CDC growth charts [25] seven subjects were obese ( > 95th percentile for age and sex) and three overweight (85-95th percentile). Using the Task Force criteria [3] eight subjects were classified as hypertensives, three as high-normal and five as normotensives. The average time between the two BP monitoring sessions was 8.6 ± 2.9 ([SD) weeks (range, 4-16 weeks). There was no difference in average CBP, HBP and ABP between the initial and the second monitoring session (Table 1 ). In both sessions there was no difference in average HBP among days 2-5.
The average number of valid HBP readings was 22.4 ± 2.2 (range, [18] [19] [20] [21] [22] [23] [24] in the first session and 22.8 ± 1.9 in the second (range, [17] [18] [19] [20] [21] [22] [23] [24] . A total of 82.8 ± 6.3 readings were obtained during the first 24-h ABP recording and 83.6 ± 4.5 during the second. A fraction of 19.2 ± 4.6% of readings were discarded and 3.1 ± 2% of time points were not represented in the first ABP recording, because both the initial and the automatically repeated reading 2 min later were considered erroneous (18.7 ± 5.4% and 3 ± 2.2% respectively in the second recording).
In both the BP monitoring sessions average systolic HBP was significantly lower than CBP (by 8.6/9.1 mmHg in the initial/second monitoring session, P < 0.01) and daytime ABP (by 12.1/15.5 mmHg, P < 0.001) ( Table 1) . Daytime ABP was higher than CBP, reaching statistical significance only in the second session (mean difference 3.5/6.4 mmHg in the initial/second monitoring session, P < 0.05 in the second session) ( Table 1 ). In regard to diastolic BP, daytime ABP was significantly higher than HBP (by 3.2/ 6.1 mmHg in the initial/second session, P < 0.05) and CBP (by 4.1/7.2 mmHg, P < 0.05), whereas no difference was found between CBP and HBP.
Test-retest correlation coefficients and SD of the differences between BP measurements of the two monitoring sessions are presented in Table 2 and Figure 1 . All correlations were statistically significant (P < 0.05) apart from those related to the diurnal BP variation (day/nighttime ABP difference and ratio). The reproducibility of CBP of the second visit (SD of differences 10.4/6.3 mmHg for systolic/diastolic) was superior to that of the initial visit (12.7/7.9 mmHg). In regard to HBP, the reproducibility of the initial day was inferior to those of the following days [SD of differences 10.1/7.4 (systolic/diastolic) for the initial day, 9.4/5.7 for the second and 9.8/5.7 for the third day]. When an average of 2 days was used (days 2-3 instead of 2-5 for each session) the SD of differences was 9.0/4.8. The reproducibility findings for the subgroup of hypertensive participants (n = 11) was similar to those of the whole study group, whereas the corresponding findings in the normotensive group were inconclusive because of the small sample studied (n = 5).
In regard to the diagnosis of hypertension made by CBP, one subject was classified as normotensive in the initial assessment and hypertensive in the second and one did the reverse. On the basis of ABP, one subject was classified as having high-normal BP in the initial assessment but was found to be normotensive in the second assessment. Classification of subjects on the basis of HBP was not performed because the threshold of normality for this method in children is not known. Eight subjects (50%) were dippers ( > 10% nocturnal decline in systolic and/or diastolic BP) in both the initial and the second assessment and three subjects were non-dippers in both (agreement between assessments in 69% of cases). However, five subjects were non-dippers in the initial assessment and dippers in the second one (disagreement in 31%).
On the basis of the reproducibility values of the three BP measurement methods ( Table 2 ) the number of subjects required for a comparative parallel trial aiming to detect a difference in the effect of two antihypertensive drugs of 10 mmHg systolic BP was 45 using CBP, 20 using HBP and 12 using 24-h ABP and for 5 mmHg diastolic BP were 67, 31 and 31, respectively. For a crossover trial the corresponding sample sizes required were 11, 5 and 3 for systolic and 16, 7 and 7 for diastolic BP, respectively.
Discussion
This study provides a direct comparison of the reproducibility of HBP with CBP and ABP in children and adolescents. To our knowledge, although several studies have addressed this issue in adults, no study has provided Table 1 Average clinic, home and ambulatory blood pressure values of the initial and the second monitoring session (systolic/diastolic; mmHg ± SD). (All differences in blood pressure between sessions were statistically non-significant) information on the reproducibility of HBP in children and adolescents. The novel information provided by this study is that in children and adolescents HBP is more reproducible than clinic pressures, whereas 24-h ABP appears to be the most reproducible method. This advantage of out-of office measurements increases the precision (or reduces the sample size) of trials of antihypertensive drug efficacy and, thereby, may facilitate the accumulation of information on the efficacy of antihypertensive drugs in children and adolescents.
In accord to previous studies in adults showing the initial assessment of either CBP or HBP to provide the most unstable BP values [26] [27] [28] , we found that CBP of the initial visit was less reproducible than of the second one and that HBP of the initial day was less reproducible than of the next days. In order to improve the reliability of BP values, we preferred to discard measurements of the initial assessment both in the clinic and at home [26] [27] [28] .
The selection of CBPs of the second visit explains, at least in part, the superior reproducibility of CBP in the present study compared to the study in children and adolescents by Lurbe et al. [13] , which was based on measurements of the initial visit ( Table 2) . The fact that some study participants performed self-measurements of HBP whereas others had their HBP measured by their parents is not expected to impact the level of HBP since it has been shown that this is affected exclusively by the setting where measurements are taken rather than the person who is taking the measurements [29] .
Comparison of out-of-office blood pressure measurements in this study confirmed our previous report showing that, in contrast to findings in adults, in children and adolescents systolic HBP is significantly lower awake ABP [30] . In regard to the reproducibility of BP measurements, several studies in adults have consistently shown ABP to be superior to CBP [6, 16, [17] [18] [19] . Only two studies by Lurbe et al. have reported data on the reproducibility of ABP monitored 4-7 months apart in normotensive children and adolescents [12, 13] (Table 2 ).
In both of these studies the SD of differences for ABP were consistent with those of the present study, supporting the validity of our study despite its small sample size. Furthermore, in line with the findings by Lurbe et al. [13] we found that parameters of the diurnal BP variation are poorly reproducible in children, as is also the case in adults [31] . Therefore, as it is the case in the adults [31] , in children and adolescents one 24-h ABP recording is not sufficient for the evaluation of the diurnal BP profile [13] .
Studies in adults have shown the reproducibility of HBP to be superior to that of CBP [6, [18] [19] [20] 28] and similar to that of ABP [6, 18, 19] . This study showed that, again in children and adolescents HBP is more reproducible than CBP ( Table 2 , Fig. 1 ). In addition, these data suggest that, in line to findings in adults [28] , in children and adolescents a short period of HBP monitoring (average of eight measurements of 2 days after the initial day) provides a reliable assessment of the level of BP at home. It should be noted however, that the reproducibility of HBP is further improved by averaging measurements of 4 days (days 2-5).
The advantageous reproducibility of HBP may be due either to the larger number of BP measurements obtained at home compared with clinic measurements, or to the fact that home measurements are taken away from the clinic setting in the usual environment of the individual child. The low BP level of home compared to clinic measurements and the improvement of the reproducibility of HBP by increasing the number of monitoring 
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days, suggest that both the above factors are important features of the method. HBP measurements may not only provide useful supplementary information to the practicing physician in regard to the white-coat effect [7, 10, 11] and the long-term follow-up of treated subjects, but may also facilitate the design of trials for the assessment of the efficacy of antihypertensive drugs in children [6, 32] by reducing the sample size required (the number of children required for a trial using HBP measurements is about half of that using CBPs).
HBP is a more standardized method of measurement in terms of posture and activity (always taken in the sitting posture, at rest and in the same environment) compared with 24-h ABP that is taken in ambulatory conditions. However, these data suggest that in children and adolescents 24-h ABP may be more reproducible than HBP (Table 2) . This difference in reproducibility between the two methods is small and may not be clinically important. However, the number of subjects analysed is quite small for the type of analysis that has been performed and, therefore, confirmation of these findings in larger trials is required.
In conclusion, these data suggest that in children and adolescents the reproducibility of HBP is superior to that of CBP and close to that of ABP. HBP appears to have considerable potential for use in clinical practice and research in hypertension in children and adolescents and therefore requires further investigation in future studies.
